Immunology and targeted therapy in Castleman disease-Reference-Cited by-同舟云学术

Immunology and targeted therapy in Castleman disease

Published:2024-05-27 Issue:9 Volume:20 Page:1101-1112
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Tsunoda Shinichiro¹^ORCID,Harada Takuya²³^ORCID,Kikushige Yoshikane²⁴^ORCID,Kishimoto Tadamitsu⁵^ORCID,Yoshizaki Kazuyuki⁶^ORCID

Affiliation:

1. Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Sumitomo Hospital, Osaka, Japan

2. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan

3. Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

4. Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan

5. Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan

6. The Institute of Scientific and Industrial Research, SANKEN, Osaka University, Osaka, Japan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2024.2357689

Reference93 articles.

1. Case 40011

2. Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In: Clark R Gumley R, editors. The year book of cancer. Chicago: Year Book Medical Publishers; 1970. p. 296–299.

3. Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia: a syndrome related to giant lymph node hyperplasia of plasma cell type];Mori S;J Jpn Soc Res (New York),1980

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Castleman Disease: A Rare Lymphoproliferative Disorder With Diverse Clinical Presentation, Diagnosis, and Treatment Approach;Cureus;2024-09-11